Antibodies & Hybridomas — page 1 of 10
Antibodies & Hybridomas
Page 1 of 10
| Specificity | Clone | Host Species | Reactive Species | Format | Size | Reviews | Supplier | |
|---|---|---|---|---|---|---|---|---|
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 001 | Rabbit | SARS-CoV, SARS-CoV-2 | unconjugated | 100 µL | n/a |
 CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 001 | Rabbit | SARS-CoV, SARS-CoV-2 | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 005 | Mouse | SARS-CoV, SARS-CoV-2 | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 005 | Mouse | SARS-CoV, SARS-CoV-2 | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | polyclonal | Rabbit | SARS-CoV, SARS-CoV-2 | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | polyclonal | Rabbit | SARS-CoV, SARS-CoV-2 | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 0006-1 | Rabbit | n/a | purified | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 0002 | Rabbit | n/a | purified | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Surface Glycoprotein Chimeric | D005 | Chimeric | SARS-CoV-2, SARS-CoV spike RBD, SARS-CoV spike S1, SARs-CoV-2 spike S1, SARS-CoV-2 spike RBD | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Surface Glycoprotein Chimeric | D005 | Chimeric | SARS-CoV-2, SARS-CoV spike RBD, SARS-CoV spike S1, SARs-CoV-2 spike S1, SARS-CoV-2 spike RBD | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| Spike Protein | CV1 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | Fab2 fragment-His-tagged | 100 µg | n/a |
 ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | Fab2 fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | Fab fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | Fab fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Rabbit | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Cat | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified, Fc-silenced | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Cat | SARS Coronavirus 2 (SARS-Cov-2) | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Human, Mouse | n/a | biotin conjugate | 50 µl|100 µl | n/a |
 ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Human, Mouse | n/a | fluorescein (FITC) conjugate | 50 µl|100 µl | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Human, Mouse | n/a | peroxidase (HRP) conjugate | 50 µl|100 µl | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Rabbit | n/a | unconjugated | 50 µl|100 µl | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Human, Mouse | n/a | affinity purified | 50 µg|100 µg | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Human, Mouse | n/a | affinity purified | 50 µl|100 µl | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Human, Mouse | n/a | affinity purified | 50 µl|100 µl | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Mouse | n/a | affinity purified | 50 µl|100 µl | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | polyclonal | Rabbit | n/a | immunogen affinity purified | 30 µl|100 µl|1 ml | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Mouse | n/a | Protein A purified | 1 mg | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Mouse | n/a | Protein A purified | 1 mg | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Human | n/a | unconjugated | 100 µl|1 ml | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Human, Mouse | n/a | unconjugated | 50 µl|100 µl|200 µl | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Human, Mouse | n/a | unconjugated | 50 µl|100 µl|200 µl | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein scFv | monoclonal | E. coli | n/a | unconjugated | 100 µl|1 ml | n/a |
ABBEXA |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | Fab2 fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | Fab2 fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | Fab fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | Fab fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Rabbit | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified, Fc-silenced | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Cat | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Cat | SARS Coronavirus 2 (SARS-Cov-2) | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 E | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 0.02 mg;0.1mg | n/a |
 CREATIVE BIOLABS |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) S1 Protein | monoclonal | Rabbit | n/a | unconjugated | 50 µl|100 µl | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) S1 Protein | monoclonal | Human | n/a | unconjugated | 100 µl|1 ml | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Trimeric Spike 1 Protein | monoclonal | Mouse | n/a | Protein A purified | 1 mg | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Trimeric Spike 1 Protein | monoclonal | Mouse | n/a | Protein A purified | 1 mg | n/a |
ABBEXA |
More Info |
| SARS-CoV-2 | 6F10 | Mouse | n/a | Protein G purified | 50 µg | n/a |
 BIOVISION, INC. |
More Info |
| SARS-CoV-2 | polyclonal | Rabbit | n/a | purified | 50 µg | n/a |
BIOVISION, INC. |
More Info |
| SARS-CoV-2 S-ECD | XX0406 | Human | SARS-CoV-2 | affinity purified | 0.1mg | n/a |
CREATIVE BIOLABS |
More Info |
| SARS-CoV-2 S-RBD | XX0409 | Human | SARS-CoV-2 | Protein G purified | 0.1mL | n/a |
CREATIVE BIOLABS |
More Info |
| SARS-CoV-2 S-RBD | XX0611 | Mouse | SARS-CoV-2 | Protein A/G purified | 0.1mg;0.2mg;0.5mg;1mg | n/a |
CREATIVE BIOLABS |
More Info |
| SARS-CoV-2 S-RBD | XX0612 | Mouse | SARS-CoV-2 | Protein A/G purified | 0.1mg;0.2mg;0.5mg;1mg | n/a |
CREATIVE BIOLABS |
More Info |
| SARS-CoV-2 S-RBD | XX0613 | Human | SARS-CoV-1, SARS-CoV-2 | Protein A/G purified | 0.1mg;0.2mg;0.5mg;1mg | n/a |
CREATIVE BIOLABS |
More Info |
| SARS-CoV-2 (COVID-19) PLpro (nsp3) | polyclonal | Rabbit | SARS coronavirus 2 | Protein A purified | 100 µl | n/a |
 GENETEX INC. |
More Info |
| SARS-CoV-2 (COVID-19) PLpro (nsp3) | polyclonal | Rabbit | SARS coronavirus 2 | antigen affinity purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV-2 S-ECD/RBD | XX0403 | Human | SARS-CoV-2 | unconjugated | 0.1mg;1.0mg | n/a |
CREATIVE BIOLABS |
More Info |
| SARS-CoV-2 S-ECD/RBD | XX0404 | Human | SARS-CoV-2 | affinity purified | 0.1mg | n/a |
CREATIVE BIOLABS |
More Info |
| SARS-CoV-2 S-ECD/RBD | XX0405 | Human | SARS-CoV-2 | affinity purified | 0.1mg | n/a |
CREATIVE BIOLABS |
More Info |
| SARS-CoV-2 S-hIgG1 | XX0411 | Human | SARS-CoV-2 | unconjugated | 0.05mL;0.1mL;0.2mL;5x0.2mL | n/a |
CREATIVE BIOLABS |
More Info |
| SARS-CoV-2 | monoclonal | Human | n/a | purified | n/a | n/a |
CREATIVE BIOLABS |
More Info |
| SARS-CoV-2 | polyclonal | Rabbit | n/a | unconjugated | n/a | n/a |
CREATIVE BIOLABS |
More Info |
| SARS-CoV-2 Whole Spike Protein | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µg | n/a |
 ROCKLAND IMMUNOCHEMICALS INC. |
More Info |
| SARS-CoV-2 Whole Spike Protein | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 500 µg | n/a |
ROCKLAND IMMUNOCHEMICALS INC. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Mouse | SARS-CoV; SARS-CoV2 | Fab2 fragment-His-tagged | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Human | SARS-CoV; SARS-CoV2 | Fab2 fragment-His-tagged | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Mouse | SARS-CoV; SARS-CoV2 | Fab2 fragment-His-tagged | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Human | SARS-CoV; SARS-CoV2 | Fab2 fragment-His-tagged | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Mouse | SARS-CoV; SARS-CoV2 | Fab fragment-His-tagged | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Human | SARS-CoV; SARS-CoV2 | Fab fragment-His-tagged | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Mouse | SARS-CoV; SARS-CoV2 | Fab fragment-His-tagged | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Human | SARS-CoV; SARS-CoV2 | Fab fragment-His-tagged | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Human | SARS-CoV; SARS-CoV2 | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Human | SARS-CoV; SARS-CoV2 | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Rabbit | SARS-CoV; SARS-CoV2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Rabbit | SARS-CoV; SARS-CoV2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Human | SARS-CoV; SARS-CoV2 | purified, Fc-silenced | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Human | SARS-CoV; SARS-CoV2 | purified, Fc-silenced | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Human | SARS-CoV; SARS-CoV2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Cat | SARS-CoV; SARS-CoV2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Human | SARS-CoV; SARS-CoV2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Cat | SARS-CoV; SARS-CoV2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Human | SARS-CoV; SARS-CoV2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Human | SARS-CoV; SARS-CoV2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Mouse | SARS-CoV; SARS-CoV2 | purified, Fc-silenced | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Mouse | SARS-CoV; SARS-CoV2 | purified, Fc-silenced | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Mouse | SARS-CoV; SARS-CoV2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |